drugset / Trial / NCT01681810

Oral Nitrite in Adults With Metabolic Syndrome and Hypertension

NCT01681810

Phase 2 Completed 20 enrolled Gladwin, Mark, MD
NaSingle-groupOpen-labelTreatment

Summary

This research study is being conducted to examine the effects of daily inorganic nitrite treatment on the cardiometabolic and hormonal disturbances observed in overweight/obese adults with the metabolic syndrome and high blood pressure. Ultimately, oral nitrite therapy may have a major impact on the prevention and treatment of both diabetes and cardiovascular disease.

Timeline

Start
2012-10
Primary completion
2018-02-08
Completion
2018-03-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 40 mg Oral